Bioactivity of analogs of the N-terminal region of gastrin-17

Jeffrey Copps, Shawn Ahmed, Richard F. Murphy, Sándor Lovas

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Gastrin-17-Gly (G17-Gly) has been shown to bind to non-CCK nanomolar and micromolar affinity sites on DLD-1 and HT-29 human colonic carcinoma cells and to stimulate cellular proliferation. However, in previous studies, we showed that C-terminal truncation of the gastrin-17 (G17) to the G17 analog G17(1-12) and then to G17(1-6)-NH2 did not remove the ability to bind to DLD-1 cells or to activate proliferation. This implies that residues and/or structural motifs required for bioactivity at these receptors rest in the N-terminal region of G17. In this work, radioligand binding studies conducted with further C-terminally truncated analogs revealed that sequences as short as G17(1-4) still bind to a single receptor with micromolar affinity. Additionally, cell proliferation assays showed that G17(1-12) stimulates proliferation of DLD-1 cells, as of HT-29 cells, but the sequences shorter than G17(1-6)-NH2, including non-amidated G17(1-6), were incapable of stimulating proliferation. These observations indicate that the tetrapeptide pGlu-Gly-Pro-Trp is the minimum N-terminal sequence for binding to the probable growth-promoting site on DLD-1 cells. Since analogs shorter than G17(1-6) are able to bind the receptor, these peptides may be of use for developing selective antagonists.

Original languageEnglish
Pages (from-to)2263-2267
Number of pages5
JournalPeptides
Volume30
Issue number12
DOIs
StatePublished - Dec 2009

Fingerprint

Bioactivity
gastrin 17
Cell Proliferation
HT29 Cells
Peptide Receptors
Cell proliferation
Assays
Cells
Carcinoma

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Endocrinology
  • Physiology
  • Cellular and Molecular Neuroscience

Cite this

Bioactivity of analogs of the N-terminal region of gastrin-17. / Copps, Jeffrey; Ahmed, Shawn; Murphy, Richard F.; Lovas, Sándor.

In: Peptides, Vol. 30, No. 12, 12.2009, p. 2263-2267.

Research output: Contribution to journalArticle

Copps, Jeffrey ; Ahmed, Shawn ; Murphy, Richard F. ; Lovas, Sándor. / Bioactivity of analogs of the N-terminal region of gastrin-17. In: Peptides. 2009 ; Vol. 30, No. 12. pp. 2263-2267.
@article{87972de9408f4360b53a891349c21444,
title = "Bioactivity of analogs of the N-terminal region of gastrin-17",
abstract = "Gastrin-17-Gly (G17-Gly) has been shown to bind to non-CCK nanomolar and micromolar affinity sites on DLD-1 and HT-29 human colonic carcinoma cells and to stimulate cellular proliferation. However, in previous studies, we showed that C-terminal truncation of the gastrin-17 (G17) to the G17 analog G17(1-12) and then to G17(1-6)-NH2 did not remove the ability to bind to DLD-1 cells or to activate proliferation. This implies that residues and/or structural motifs required for bioactivity at these receptors rest in the N-terminal region of G17. In this work, radioligand binding studies conducted with further C-terminally truncated analogs revealed that sequences as short as G17(1-4) still bind to a single receptor with micromolar affinity. Additionally, cell proliferation assays showed that G17(1-12) stimulates proliferation of DLD-1 cells, as of HT-29 cells, but the sequences shorter than G17(1-6)-NH2, including non-amidated G17(1-6), were incapable of stimulating proliferation. These observations indicate that the tetrapeptide pGlu-Gly-Pro-Trp is the minimum N-terminal sequence for binding to the probable growth-promoting site on DLD-1 cells. Since analogs shorter than G17(1-6) are able to bind the receptor, these peptides may be of use for developing selective antagonists.",
author = "Jeffrey Copps and Shawn Ahmed and Murphy, {Richard F.} and S{\'a}ndor Lovas",
year = "2009",
month = "12",
doi = "10.1016/j.peptides.2009.09.012",
language = "English",
volume = "30",
pages = "2263--2267",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Bioactivity of analogs of the N-terminal region of gastrin-17

AU - Copps, Jeffrey

AU - Ahmed, Shawn

AU - Murphy, Richard F.

AU - Lovas, Sándor

PY - 2009/12

Y1 - 2009/12

N2 - Gastrin-17-Gly (G17-Gly) has been shown to bind to non-CCK nanomolar and micromolar affinity sites on DLD-1 and HT-29 human colonic carcinoma cells and to stimulate cellular proliferation. However, in previous studies, we showed that C-terminal truncation of the gastrin-17 (G17) to the G17 analog G17(1-12) and then to G17(1-6)-NH2 did not remove the ability to bind to DLD-1 cells or to activate proliferation. This implies that residues and/or structural motifs required for bioactivity at these receptors rest in the N-terminal region of G17. In this work, radioligand binding studies conducted with further C-terminally truncated analogs revealed that sequences as short as G17(1-4) still bind to a single receptor with micromolar affinity. Additionally, cell proliferation assays showed that G17(1-12) stimulates proliferation of DLD-1 cells, as of HT-29 cells, but the sequences shorter than G17(1-6)-NH2, including non-amidated G17(1-6), were incapable of stimulating proliferation. These observations indicate that the tetrapeptide pGlu-Gly-Pro-Trp is the minimum N-terminal sequence for binding to the probable growth-promoting site on DLD-1 cells. Since analogs shorter than G17(1-6) are able to bind the receptor, these peptides may be of use for developing selective antagonists.

AB - Gastrin-17-Gly (G17-Gly) has been shown to bind to non-CCK nanomolar and micromolar affinity sites on DLD-1 and HT-29 human colonic carcinoma cells and to stimulate cellular proliferation. However, in previous studies, we showed that C-terminal truncation of the gastrin-17 (G17) to the G17 analog G17(1-12) and then to G17(1-6)-NH2 did not remove the ability to bind to DLD-1 cells or to activate proliferation. This implies that residues and/or structural motifs required for bioactivity at these receptors rest in the N-terminal region of G17. In this work, radioligand binding studies conducted with further C-terminally truncated analogs revealed that sequences as short as G17(1-4) still bind to a single receptor with micromolar affinity. Additionally, cell proliferation assays showed that G17(1-12) stimulates proliferation of DLD-1 cells, as of HT-29 cells, but the sequences shorter than G17(1-6)-NH2, including non-amidated G17(1-6), were incapable of stimulating proliferation. These observations indicate that the tetrapeptide pGlu-Gly-Pro-Trp is the minimum N-terminal sequence for binding to the probable growth-promoting site on DLD-1 cells. Since analogs shorter than G17(1-6) are able to bind the receptor, these peptides may be of use for developing selective antagonists.

UR - http://www.scopus.com/inward/record.url?scp=70449642388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449642388&partnerID=8YFLogxK

U2 - 10.1016/j.peptides.2009.09.012

DO - 10.1016/j.peptides.2009.09.012

M3 - Article

VL - 30

SP - 2263

EP - 2267

JO - Peptides

JF - Peptides

SN - 0196-9781

IS - 12

ER -